20:03 EDT Cathie Wood’s ARK Investment buys 460K shares of Recursion Pharmaceuticals (RXRX) today
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Biotech Alert: Searches spiking for these stocks today
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
- Recursion Pharmaceuticals, Enamine release new tools in its AI/ML platform
- Recursion announces first patient dosed in Phase 1 REC-3565 study